| Design and endpoints of clinical trials in hepatocellular carcinoma JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ... Journal of the National Cancer Institute 100 (10), 698-711, 2008 | 1630 | 2008 |
| Mechanisms of hepatotoxicity H Jaeschke, GJ Gores, AI Cederbaum, JA Hinson, D Pessayre, ... Toxicological sciences 65 (2), 166-176, 2002 | 1394 | 2002 |
| Biliary tract cancers PC De Groen, GJ Gores, NF LaRusso, LL Gunderson, DM Nagorney New England Journal of Medicine 341 (18), 1368-1378, 1999 | 1038 | 1999 |
| Diagnosis and management of primary sclerosing cholangitis R Chapman, J Fevery, A Kalloo, DM Nagorney, KM Boberg, B Shneider, ... Hepatology 51 (2), 660-678, 2010 | 990 | 2010 |
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis AE Feldstein, A Canbay, P Angulo, M Taniai, LJ Burgart, KD Lindor, ... Gastroenterology 125 (2), 437-443, 2003 | 970 | 2003 |
| mir-29 regulates Mcl-1 protein expression and apoptosis JL Mott, S Kobayashi, SF Bronk, GJ Gores Oncogene 26 (42), 6133, 2007 | 899 | 2007 |
| Hepatocellular carcinoma: clinical frontiers and perspectives J Bruix, GJ Gores, V Mazzaferro Gut 63 (5), 844-855, 2014 | 869 | 2014 |
| Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway AE Feldstein, NW Werneburg, A Canbay, ME Guicciardi, SF Bronk, ... Hepatology 40 (1), 185-194, 2004 | 852 | 2004 |
| Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c ME Guicciardi, J Deussing, H Miyoshi, SF Bronk, PA Svingen, C Peters, ... The Journal of clinical investigation 106 (9), 1127-1137, 2000 | 787 | 2000 |
| Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: a pilot study J Laurin, KD Lindor, JS Crippin, A Gossard, GJ Gores, J Ludwig, J Rakela, ... Hepatology 23 (6), 1464-1467, 1996 | 773 | 1996 |
| Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report PA Clavien, M Lesurtel, PMM Bossuyt, GJ Gores, B Langer, A Perrier The lancet oncology 13 (1), e11-e22, 2012 | 744 | 2012 |
| Apoptosis and necrosis in the liver: a tale of two deaths? H Malhi, GJ Gores, JJ Lemasters Hepatology 43 (S1), S31-S44, 2006 | 727 | 2006 |
| Lysosomes in cell death ME Guicciardi, M Leist, GJ Gores Oncogene 23 (16), 2881, 2004 | 685 | 2004 |
| Cholangiocarcinoma N Razumilava, GJ Gores The Lancet 383 (9935), 2168-2179, 2014 | 660 | 2014 |
| Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism M Jaiswal, NF LaRusso, LJ Burgart, GJ Gores Cancer research 60 (1), 184-190, 2000 | 660 | 2000 |
| The role of proteases during apoptosis. T Patel, GJ Gores, SH Kaufmann The FASEB Journal 10 (5), 587-597, 1996 | 655 | 1996 |
| Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment B Blechacz, GJ Gores Hepatology 48 (1), 308-321, 2008 | 633 | 2008 |
| Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis H Malhi, SF Bronk, NW Werneburg, GJ Gores Journal of Biological Chemistry 281 (17), 12093-12101, 2006 | 604 | 2006 |
| Pathogenesis, diagnosis, and management of cholangiocarcinoma S Rizvi, GJ Gores Gastroenterology 145 (6), 1215-1229, 2013 | 601 | 2013 |
| Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma DJ Rea, JK Heimbach, CB Rosen, MG Haddock, SR Alberts, WK Kremers, ... Annals of surgery 242 (3), 451, 2005 | 599 | 2005 |
